 |
PDBsum entry 1lgo
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Biosynthetic protein
|
PDB id
|
|
|
|
1lgo
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
277:47476-47485
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of OxyB, a cytochrome P450 implicated in an oxidative phenol coupling reaction during vancomycin biosynthesis.
|
|
K.Zerbe,
O.Pylypenko,
F.Vitali,
W.Zhang,
S.Rouset,
M.Heck,
J.W.Vrijbloed,
D.Bischoff,
B.Bister,
R.D.Süssmuth,
S.Pelzer,
W.Wohlleben,
J.A.Robinson,
I.Schlichting.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Gene-inactivation studies point to the involvement of OxyB in catalyzing the
first oxidative phenol coupling reaction during glycopeptide antibiotic
biosynthesis. The oxyB gene has been cloned and sequenced from the vancomycin
producer Amycolatopsis orientalis, and the hemoprotein has been produced in
Escherichia coli, crystallized, and its structure determined to 1.7-A
resolution. OxyB gave UV-visible spectra characteristic of a P450-like
hemoprotein in the low spin ferric state. After reduction to the ferrous state
by dithionite or by spinach ferredoxin and ferredoxin reductase, the CO-ligated
form gave a 450-nm peak in a UV-difference spectrum. Addition of putative
heptapeptide substrates to resting OxyB produced type I changes to the UV
spectrum, but no turnover was observed in the presence of ferredoxin and
ferredoxin reductase, showing that either the peptides or the reduction system,
or both, are insufficient to support a full catalytic cycle. OxyB exhibits the
typical P450-fold, with helix L containing the signature sequence FGHGXHXCLG and
Cys(347) being the proximal axial thiolate ligand of the heme iron. The
structural similarity of OxyB is highest to P450nor, P450terp, CYP119, and
P450eryF. In OxyB, the F and G helices are rotated out of the active site
compared with P450nor, resulting in a much more open active site, consistent
with the larger size of the presumed heptapeptide substrate.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Structures of glycopeptide antibiotics and
putative linear heptapeptide intermediates (18-20) (1) in
vancomycin biosynthesis.
|
 |
Figure 2.
Fig. 2. The organization of ORFs in the DNA isolated from
the vancomycin producer A. orientalis. On the left side is the
3'-terminal end of the peptide synthetase-3 and on the right
side the 5'-terminal end of the halogenase gene (14). The oxyA,
oxyB, and oxyC genes are indicated.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2002,
277,
47476-47485)
copyright 2002.
|
|
| |
Figures were
selected
by the author.
|
|
|
| |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
|
| |
Gene-inactivation studies point to the involvement of OxyB in
catalyzing the first oxidative phenol coupling reaction during
glycopeptide antibiotic biosynthesis. The oxyB gene has been cloned
and sequenced from the vancomycin producer Amycolatopsis orientalis,
and the hemoprotein has been produced in Escherichia coli,
crystallized, and its structure determined to 1.7Å
resolution. OxyB gave UV-visible spectra characteristic of a P450-like
hemoprotein in the low spin ferric state. After reduction to the
ferrous state by dithionite or by spinach ferredoxin and ferredoxin
reductase, the CO-ligated form gave a 450-nm peak in a UV-difference
spectrum. Addition of putative heptapeptide substrates to resting OxyB
produced type I changes to the UV spectrum, but no turnover was
observed in the presence of ferredoxin and ferredoxin reductase,
showing that either the peptides or the reduction system, or both, are
insufficient to support a full catalytic cycle. OxyB exhibits the
typical P450-fold, with helix L containing the signature sequence
FGHGXHXCLG and Cys347 being the proximal axial thiolate ligand of the
heme iron. The structural similarity of OxyB is highest to P450nor,
P450terp, CYP119, and P450eryF. In OxyB, the F and G helices are
rotated out of the active site compared with P450nor, resulting in a
much more open active site, consistent with the larger size of the
presumed heptapeptide substrate.
Ilme Schlichting
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.J.Cryle
(2011).
Carrier protein substrates in cytochrome P450-catalysed oxidation.
|
| |
Metallomics,
3,
323-326.
|
 |
|
|
|
|
 |
P.K.Sydor,
S.M.Barry,
O.M.Odulate,
F.Barona-Gomez,
S.W.Haynes,
C.Corre,
L.Song,
and
G.L.Challis
(2011).
Regio- and stereodivergent antibiotic oxidative carbocyclizations catalysed by Rieske oxygenase-like enzymes.
|
| |
Nat Chem,
3,
388-392.
|
 |
|
|
|
|
 |
Y.T.Lee,
E.C.Glazer,
R.F.Wilson,
C.D.Stout,
and
D.B.Goodin
(2011).
Three clusters of conformational States in p450cam reveal a multistep pathway for closing of the substrate access channel .
|
| |
Biochemistry,
50,
693-703.
|
 |
|
|
|
|
 |
Z.Li,
S.G.Rupasinghe,
M.A.Schuler,
and
S.K.Nair
(2011).
Crystal structure of a phenol-coupling P450 monooxygenase involved in teicoplanin biosynthesis.
|
| |
Proteins,
79,
1728-1738.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.T.Walsh,
and
M.A.Fischbach
(2010).
Natural products version 2.0: connecting genes to molecules.
|
| |
J Am Chem Soc,
132,
2469-2493.
|
 |
|
|
|
|
 |
H.Ouellet,
J.B.Johnston,
and
P.R.Ortiz de Montellano
(2010).
The Mycobacterium tuberculosis cytochrome P450 system.
|
| |
Arch Biochem Biophys,
493,
82-95.
|
 |
|
|
|
|
 |
T.C.Pochapsky,
S.Kazanis,
and
M.Dang
(2010).
Conformational plasticity and structure/function relationships in cytochromes P450.
|
| |
Antioxid Redox Signal,
13,
1273-1296.
|
 |
|
|
|
|
 |
Y.T.Lee,
R.F.Wilson,
I.Rupniewski,
and
D.B.Goodin
(2010).
P450cam visits an open conformation in the absence of substrate.
|
| |
Biochemistry,
49,
3412-3419.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.M.Nolan,
and
C.T.Walsh
(2009).
How nature morphs peptide scaffolds into antibiotics.
|
| |
Chembiochem,
10,
34-53.
|
 |
|
|
|
|
 |
L.H.Xu,
S.Fushinobu,
H.Ikeda,
T.Wakagi,
and
H.Shoun
(2009).
Crystal structures of cytochrome P450 105P1 from Streptomyces avermitilis: conformational flexibility and histidine ligation state.
|
| |
J Bacteriol,
191,
1211-1219.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.F.Widboom,
and
S.D.Bruner
(2009).
Complex oxidation chemistry in the biosynthetic pathways to vancomycin/teicoplanin antibiotics.
|
| |
Chembiochem,
10,
1757-1764.
|
 |
|
|
|
|
 |
P.Gao,
and
Y.Huang
(2009).
Detection, distribution, and organohalogen compound discovery implications of the reduced flavin adenine dinucleotide-dependent halogenase gene in major filamentous actinomycete taxonomic groups.
|
| |
Appl Environ Microbiol,
75,
4813-4820.
|
 |
|
|
|
|
 |
A.N.Holding,
and
J.B.Spencer
(2008).
Investigation into the mechanism of phenolic couplings during the biosynthesis of glycopeptide antibiotics.
|
| |
Chembiochem,
9,
2209-2214.
|
 |
|
|
|
|
 |
K.Woithe,
N.Geib,
O.Meyer,
T.Wörtz,
K.Zerbe,
and
J.A.Robinson
(2008).
Exploring the substrate specificity of OxyB, a phenol coupling P450 enzyme involved in vancomycin biosynthesis.
|
| |
Org Biomol Chem,
6,
2861-2867.
|
 |
|
|
|
|
 |
M.J.Cryle,
and
I.Schlichting
(2008).
Structural insights from a P450 Carrier Protein complex reveal how specificity is achieved in the P450(BioI) ACP complex.
|
| |
Proc Natl Acad Sci U S A,
105,
15696-15701.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.W.Munro,
H.M.Girvan,
and
K.J.McLean
(2007).
Variations on a (t)heme--novel mechanisms, redox partners and catalytic functions in the cytochrome P450 superfamily.
|
| |
Nat Prod Rep,
24,
585-609.
|
 |
|
|
|
|
 |
E.Stegmann,
C.Rausch,
S.Stockert,
D.Burkert,
and
W.Wohlleben
(2006).
The small MbtH-like protein encoded by an internal gene of the balhimycin biosynthetic gene cluster is not required for glycopeptide production.
|
| |
FEMS Microbiol Lett,
262,
85-92.
|
 |
|
|
|
|
 |
M.J.de Groot
(2006).
Designing better drugs: predicting cytochrome P450 metabolism.
|
| |
Drug Discov Today,
11,
601-606.
|
 |
|
|
|
|
 |
V.B.Urlacher,
and
S.Eiben
(2006).
Cytochrome P450 monooxygenases: perspectives for synthetic application.
|
| |
Trends Biotechnol,
24,
324-330.
|
 |
|
|
|
|
 |
D.Bischoff,
B.Bister,
M.Bertazzo,
V.Pfeifer,
E.Stegmann,
G.J.Nicholson,
S.Keller,
S.Pelzer,
W.Wohlleben,
and
R.D.Süssmuth
(2005).
The biosynthesis of vancomycin-type glycopeptide antibiotics--a model for oxidative side-chain cross-linking by oxygenases coupled to the action of peptide synthetases.
|
| |
Chembiochem,
6,
267-272.
|
 |
|
|
|
|
 |
D.Bo Li,
and
J.A.Robinson
(2005).
An improved solid-phase methodology for the synthesis of putative hexa- and heptapeptide intermediates in vancomycin biosynthesis.
|
| |
Org Biomol Chem,
3,
1233-1239.
|
 |
|
|
|
|
 |
L.Lehtiö,
I.Fabrichniy,
T.Hansen,
P.Schönheit,
and
A.Goldman
(2005).
Unusual twinning in an acetyl coenzyme A synthetase (ADP-forming) from Pyrococcus furiosus.
|
| |
Acta Crystallogr D Biol Crystallogr,
61,
350-354.
|
 |
|
|
|
|
 |
J.Clardy,
and
C.Walsh
(2004).
Lessons from natural molecules.
|
| |
Nature,
432,
829-837.
|
 |
|
|
|
|
 |
L.M.Podust,
H.Bach,
Y.Kim,
D.C.Lamb,
M.Arase,
D.H.Sherman,
S.L.Kelly,
and
M.R.Waterman
(2004).
Comparison of the 1.85 A structure of CYP154A1 from Streptomyces coelicolor A3(2) with the closely related CYP154C1 and CYPs from antibiotic biosynthetic pathways.
|
| |
Protein Sci,
13,
255-268.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
O.Puk,
D.Bischoff,
C.Kittel,
S.Pelzer,
S.Weist,
E.Stegmann,
R.D.Süssmuth,
and
W.Wohlleben
(2004).
Biosynthesis of chloro-beta-hydroxytyrosine, a nonproteinogenic amino acid of the peptidic backbone of glycopeptide antibiotics.
|
| |
J Bacteriol,
186,
6093-6100.
|
 |
|
|
|
|
 |
O.Pylypenko,
and
I.Schlichting
(2004).
Structural aspects of ligand binding to and electron transfer in bacterial and fungal P450s.
|
| |
Annu Rev Biochem,
73,
991.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |